Trial Profile
A Double Blind, Placebo-controlled, Randomized, 15-day Treatment, Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil Administered Orally to Healthy Male Volunteers Including a Scopolamine Challenge
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jan 2020
Price :
$35
*
At a glance
- Drugs THN-201 (Primary) ; Donepezil; Mefloquine
- Indications Cognition disorders
- Focus Pharmacodynamics
- Sponsors Theranexus
- 21 Jan 2020 Status changed from active, no longer recruiting to completed.
- 25 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 09 Sep 2019 Planned End Date changed from 31 Jul 2019 to 20 Dec 2019.